dabigatran has been researched along with Diabetes Mellitus, Type 2 in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 4 (44.44) | 2.80 |
| Authors | Studies |
|---|---|
| Avvisati, G; Bressi, E; Cerchiara, E; De Caterina, R; Di Sciascio, G; Giannetti, B; Patti, G; Veneri, AD | 1 |
| Babor, R; Beban, G; Booth, M; Grainger, B; Holloway, R; Merriman, E; Royle, G; Young, L | 1 |
| Bihaqi, SW; Grammas, P; Iannucci, J; Sen, A; Vittal Rao, H | 1 |
| Abdelgawwad, K; Brescia, CW; Coleman, CI; Costa, OS; O'Donnell, B; Sood, N; Vardar, B | 1 |
| González-Rico, MA; Juan-García, I; Miguel-Carrasco, A; Puchades-Montesa, MJ; Ramos-Tomás, C; Ribés-Cruz, JJ; Solís-Salguero, MA; Tejedor-Alonso, S; Tomás-Simó, P; Torregrosa-Maicas, I; Zambrano-Esteves, P | 1 |
| Bachellerie, B; Conil, JM; Crognier, L; Fourcade, O; Georges, B; Ruiz, S; Seguin, T | 1 |
| Berrouschot, J; Eschenfelder, CC; Hogh, T; Stoll, A | 1 |
| Alvarez, M; de Gea-García, JH; Jiménez-Parra, JD; Ruiz-Villa, G | 1 |
| Nendaz, M; Perrier, A | 1 |
1 trial(s) available for dabigatran and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Evidence of impaired dabigatran absorption following laparoscopic Roux-en-Y gastric bypass surgery: the Auckland regional experience (2011-2018).
Topics: Aged; Aged, 80 and over; Dabigatran; Diabetes Mellitus, Type 2; Female; Gastric Bypass; Humans; Laparoscopy; Male; Middle Aged; New Zealand | 2020 |
8 other study(ies) available for dabigatran and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Endothelial Dysfunction, Fibrinolytic Activity, and Coagulation Activity in Patients With Atrial Fibrillation According to Type II Diabetes Mellitus Status.
Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Carboxypeptidase B2; Case-Control Studies; Comorbidity; Cross-Sectional Studies; Dabigatran; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Endothelium, Vascular; Factor Xa Inhibitors; Female; Humans; Hypoglycemic Agents; Insulin; Italy; Male; Metformin; Peptide Fragments; Prothrombin; Sulfonylurea Compounds; von Willebrand Factor | 2020 |
Thrombin Signaling Contributes to High Glucose-Induced Injury of Human Brain Microvascular Endothelial Cells.
Topics: Alzheimer Disease; Antithrombins; Brain; Cyclic AMP Response Element-Binding Protein; Dabigatran; Diabetes Mellitus, Type 2; Endothelial Cells; Endothelium, Vascular; Glucose; Humans; Inflammation; Interleukin-6; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Microvessels; NADPH Oxidase 4; Nitric Oxide Synthase Type II; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Thrombin; Tumor Necrosis Factor-alpha; Up-Regulation | 2021 |
Kidney, limb and ophthalmic complications, and death in patients with nonvalvular atrial fibrillation and type 2 diabetes prescribed rivaroxaban or warfarin: an electronic health record analysis.
Topics: Anticoagulants; Atrial Fibrillation; Dabigatran; Diabetes Mellitus, Type 2; Electronic Health Records; Eye Diseases; Humans; Kidney; Kidney Diseases; Retrospective Studies; Rivaroxaban; Stroke; Treatment Outcome; Warfarin | 2021 |
Dabigatran-induced upper intestinal bleeding in a patient with chronic kidney disease.
Topics: Aged, 80 and over; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Diabetes Mellitus, Type 2; Erythrocyte Transfusion; Female; Gastrointestinal Hemorrhage; Glomerular Filtration Rate; Humans; Hypertension; Metabolic Clearance Rate; Renal Dialysis; Renal Insufficiency, Chronic; Thrombophilia; Urinary Tract Infections | 2013 |
[Patient with acute renal injury presenting dabigatran overdose: Hemodialysis for surgery].
Topics: Acute Kidney Injury; Aged, 80 and over; Alzheimer Disease; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Blood Coagulation Disorders; Dabigatran; Diabetes Mellitus, Type 2; Drug Overdose; Hemorrhage; Humans; Hyperkalemia; Male; Neoplasms; Phlebitis; Renal Dialysis | 2014 |
Intravenous Thrombolysis With Recombinant Tissue-Type Plasminogen Activator in a Stroke Patient Receiving Dabigatran Anticoagulant After Antagonization With Idarucizumab.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antidotes; Atrial Fibrillation; Brain Ischemia; Dabigatran; Diabetes Mellitus, Type 2; Humans; Hypertension; Infarction, Middle Cerebral Artery; Male; Paresis; Recombinant Proteins; Recovery of Function; Severity of Illness Index; Thrombolytic Therapy; Thrombophilia; Tissue Plasminogen Activator | 2016 |
[Wünderlich syndrome in patient anticoagulated with dabigatran].
Topics: Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Brain Ischemia; Carcinoma, Transitional Cell; Dabigatran; Diabetes Mellitus, Type 2; Hematoma; Humans; Kidney Diseases; Kidney Failure, Chronic; Male; Nephrectomy; Pulmonary Disease, Chronic Obstructive; Retroperitoneal Space; Tomography, X-Ray Computed; Urinary Bladder Neoplasms | 2013 |
[Update in hospital internal medicine (2007): a selection].
Topics: Anti-Bacterial Agents; Anticoagulants; Benzimidazoles; Bone Density Conservation Agents; Community-Acquired Infections; Coronary Disease; Dabigatran; Defibrillators, Implantable; Diabetes Mellitus, Type 2; Fractures, Bone; Heart Failure; Heart Neoplasms; Hip Prosthesis; Hospital Departments; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Internal Medicine; Liver Cirrhosis; Oligosaccharides; Osteoporosis; Peritonitis; Pneumonia, Bacterial; Pulmonary Embolism; Pyridines; Quality of Health Care; Risk Factors; Stroke; Teaching; Tomography, X-Ray Computed; Venous Thrombosis | 2008 |